169 related articles for article (PubMed ID: 32805233)
1. S100A4/Nonmuscle Myosin IIA/p53 Axis Contributes to Aggressive Features in Ovarian High-Grade Serous Carcinoma.
Hiruta A; Oguri Y; Yokoi A; Matsumoto T; Oda Y; Tomohiro M; Hashimura M; Jiang Z; Tochimoto M; Nakagawa M; Saegusa M
Am J Pathol; 2020 Nov; 190(11):2304-2316. PubMed ID: 32805233
[TBL] [Abstract][Full Text] [Related]
2. A functional role of S100A4/non-muscle myosin IIA axis for pro-tumorigenic vascular functions in glioblastoma.
Inukai M; Yokoi A; Ishizuka Y; Hashimura M; Matsumoto T; Oguri Y; Nakagawa M; Ishibashi Y; Ito T; Kumabe T; Saegusa M
Cell Commun Signal; 2022 Apr; 20(1):46. PubMed ID: 35392912
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of cancer-initiating cells stemness properties by abrogating S100A4 calcium binding ability in head and neck cancers.
Cheng LH; Hung KF; Huang TF; Hsieh HP; Wang SY; Huang CY; Lo JF
Oncotarget; 2016 Nov; 7(48):78946-78957. PubMed ID: 27793047
[TBL] [Abstract][Full Text] [Related]
4. Competing Roles of Ca
Yildirim A; Tekpinar M; Wassenaar TA
J Phys Chem B; 2021 Sep; 125(36):10059-10071. PubMed ID: 34464144
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of fibronectin following loss of p53 function is a poor prognostic factor in ovarian carcinoma with a unique immunophenotype.
Yokoi A; Matsumoto T; Oguri Y; Hasegawa Y; Tochimoto M; Nakagawa M; Saegusa M
Cell Commun Signal; 2020 Jul; 18(1):103. PubMed ID: 32635925
[TBL] [Abstract][Full Text] [Related]
6. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
7. Crystal structure of the S100A4-nonmuscle myosin IIA tail fragment complex reveals an asymmetric target binding mechanism.
Kiss B; Duelli A; Radnai L; Kékesi KA; Katona G; Nyitray L
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6048-53. PubMed ID: 22460785
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric mode of Ca²⁺-S100A4 interaction with nonmuscle myosin IIA generates nanomolar affinity required for filament remodeling.
Elliott PR; Irvine AF; Jung HS; Tozawa K; Pastok MW; Picone R; Badyal SK; Basran J; Rudland PS; Barraclough R; Lian LY; Bagshaw CR; Kriajevska M; Barsukov IL
Structure; 2012 Apr; 20(4):654-66. PubMed ID: 22483112
[TBL] [Abstract][Full Text] [Related]
9. Putative stem cells and epithelial-mesenchymal transition revealed in sections of ovarian tumor in patients with serous ovarian carcinoma using immunohistochemistry for vimentin and pluripotency-related markers.
Kenda Suster N; Smrkolj S; Virant-Klun I
J Ovarian Res; 2017 Feb; 10(1):11. PubMed ID: 28231820
[TBL] [Abstract][Full Text] [Related]
10. Two functional S100A4 monomers are necessary for regulating nonmuscle myosin-IIA and HCT116 cell invasion.
House RP; Pozzuto M; Patel P; Dulyaninova NG; Li ZH; Zencheck WD; Vitolo MI; Weber DJ; Bresnick AR
Biochemistry; 2011 Aug; 50(32):6920-32. PubMed ID: 21721535
[TBL] [Abstract][Full Text] [Related]
11. S100A4/non-muscle myosin II signaling regulates epithelial-mesenchymal transition and stemness in uterine carcinosarcoma.
Tochimoto M; Oguri Y; Hashimura M; Konno R; Matsumoto T; Yokoi A; Kodera Y; Saegusa M
Lab Invest; 2020 May; 100(5):682-695. PubMed ID: 31857700
[TBL] [Abstract][Full Text] [Related]
12. The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA.
Li ZH; Bresnick AR
Cancer Res; 2006 May; 66(10):5173-80. PubMed ID: 16707441
[TBL] [Abstract][Full Text] [Related]
13. Anaplastic Lymphoma Kinase Overexpression Is Associated with Aggressive Phenotypic Characteristics of Ovarian High-Grade Serous Carcinoma.
Matsumoto T; Oda Y; Hasegawa Y; Hashimura M; Oguri Y; Inoue H; Yokoi A; Tochimoto M; Nakagawa M; Jiang Z; Saegusa M
Am J Pathol; 2021 Oct; 191(10):1837-1850. PubMed ID: 34214505
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of nuclear factor-kappa B enhances the tumor growth of ovarian cancer cell line derived from a low-grade papillary serous carcinoma in p53-independent pathway.
Xiao X; Yang G; Bai P; Gui S; Nyuyen TM; Mercado-Uribe I; Yang M; Zou J; Li Q; Xiao J; Chang B; Liu G; Wang H; Liu J
BMC Cancer; 2016 Aug; 16():582. PubMed ID: 27484466
[TBL] [Abstract][Full Text] [Related]
15. Sulfiredoxin redox-sensitive interaction with S100A4 and non-muscle myosin IIA regulates cancer cell motility.
Bowers RR; Manevich Y; Townsend DM; Tew KD
Biochemistry; 2012 Oct; 51(39):7740-54. PubMed ID: 22934964
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive in situ analysis of ALDH1 and SOX2 reveals increased expression of stem cell markers in high-grade serous carcinomas compared to low-grade serous carcinomas and atypical proliferative serous tumors.
Fischer AK; Pham DL; Bösmüller H; Lengerke C; Wagner P; Bachmann C; Beschorner C; Perner S; Kommoss S; Fend F; Staebler A
Virchows Arch; 2019 Oct; 475(4):479-488. PubMed ID: 31451895
[TBL] [Abstract][Full Text] [Related]
17. Targeted Genomic Sequencing Reveals Novel
Jung YY; Woo HY; Kim HS
Anticancer Res; 2019 Jun; 39(6):2883-2889. PubMed ID: 31177126
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia upregulates ovarian cancer invasiveness via the binding of HIF-1α to a hypoxia-induced, methylation-free hypoxia response element of S100A4 gene.
Horiuchi A; Hayashi T; Kikuchi N; Hayashi A; Fuseya C; Shiozawa T; Konishi I
Int J Cancer; 2012 Oct; 131(8):1755-67. PubMed ID: 22287060
[TBL] [Abstract][Full Text] [Related]
19. The epithelial-mesenchymal transition mediator S100A4 maintains cancer-initiating cells in head and neck cancers.
Lo JF; Yu CC; Chiou SH; Huang CY; Jan CI; Lin SC; Liu CJ; Hu WY; Yu YH
Cancer Res; 2011 Mar; 71(5):1912-23. PubMed ID: 21169409
[TBL] [Abstract][Full Text] [Related]
20. S100A4 regulates macrophage invasion by distinct myosin-dependent and myosin-independent mechanisms.
Dulyaninova NG; Ruiz PD; Gamble MJ; Backer JM; Bresnick AR
Mol Biol Cell; 2018 Mar; 29(5):632-642. PubMed ID: 29282275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
